MedChem Express (MCE) - New Products 2025
Learn about the latest products from MedChemExpress (MCE), including more than 100,000 bioactive compounds, dye reagents, peptides and natural compounds for laboratory and scientific use.
- Over 100’000 bioactive molecules in stock
- Target 1000+ key proteins in 20+ signaling pathways
- Quality reports (LC/MS, NMR and HPLC) for each product
- Release of more than 1’000 newest biochemicals per month
- Data sheet with detailed biological information
- High purity & competitive prices
Small Selection of New Products
ALC-0315
HY-138170
Infection
Liposome, SARS-CoV
ALC-0315 is an ionizable aminolipid used for mRNA compaction and delivery, aiding cytoplasmic release via suspected endosomal destabilization. It forms lipid nanoparticles (LNPs), essential for mRNA COVID-19 vaccine research.
SM-102
HY-134541
Infection
Liposome
SM-102 is an amino cationic lipid useful in the formation of lipid nanoparticles (LNPs). SM-102 has higher transfection efficiency. SM-102 plays an important role in the effectiveness of lipid nanoparticles (LNPs) in delivering mRNA therapeutics and vaccines .
MMAE-d8
HY-15162A
Cancer
Microtubule/TubulinADC Cytotoxin
MMAE-d8 is a deuterated analog of MMAE, a potent mitotic and tubulin inhibitor. It retains MMAE’s microtubule-targeting properties while enhancing stability for research, particularly in antibody-drug conjugate (ADC) studies.
Rezetecán
HY-147408
Cancer
Topoisomerase, ADC Cytotoxin
Rezetecán (SHR9265) is a topoisomerase I inhibitor. In addition, Rezetecán can be used to synthesize Trastuzumab rezetecan, an antineoplastic agent. Rezetecán can be used as a cytotoxic payload (ADC Cytotoxin) in antibody-drug conjugates (ADCs) .
Lunresertib
HY-145817A
Cancer
Wee1
Lunresertib (RP-6306) is a potent, selective and orally active PKMYT1 inhibitor with an IC50 of 14 nM. lunresertib shows a high degree of selectivity over other kinases in cellular binding assays. lunresertib shows anticancer effects.
ART558
HY-141520
Cancer
DNA/RNA Synthesis
ART558 is a nanomolar potent, selective, low molecular weight, allosteric DNA polymerase activity of Polθ inhibitor (IC50=7.9 nM). ART558 can be used for the research of cancer.
19 Publications.
